Bromperidol decanoate vs placebo
Relapse · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Findings
What do systematic reviews say?
13 questions · 13 findings · 1 reviews
No studies found 0 · 0%GRADE not reported 4 · 30.8%Very low 5 · 38.5%Low 4 · 30.8%Moderate 0 · 0%High 0 · 0%
Bromperidol decanoate vs other depot antipsychotic drugs
Quality of life · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Bromperidol decanoate vs other depot antipsychotic drugs
Adverse effects ‐ needing anticholinergic drugs · patients with schizophrenia
It is very uncertain whether bromperidol decanoate changes adverse effects ‐ needing anticholinergic drugs compared with other depot antipsychotic drugs (very low certainty).
1 finding from 1 review
- RR 0.8 [0.63, 1.02]3 studies · 97 participantsVery low
Bromperidol decanoate vs other depot antipsychotic drugs
Adverse effects ‐ anticholinergic effects · patients with schizophrenia
It is very uncertain whether bromperidol decanoate changes adverse effects ‐ anticholinergic effects compared with other depot antipsychotic drugs (very low certainty).
1 finding from 1 review
- RR 3.13 [0.7, 13.95]1 study · 47 participantsVery low
Bromperidol decanoate vs other depot antipsychotic drugs
Adverse effects ‐ movement disorders · patients with schizophrenia
It is very uncertain whether bromperidol decanoate changes adverse effects ‐ movement disorders compared with other depot antipsychotic drugs (very low certainty).
1 finding from 1 review
- RR 0.74 [0.47, 1.17]2 studies · 77 participantsVery low
Bromperidol decanoate vs placebo
Hospital admissions · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Bromperidol decanoate vs placebo
Global state: Response ‐ proxy outcome ‐ mental state: 1. General ‐ average score (Brief Psychiatric Rating Scale by over 24 weeks · patients with schizophrenia
1 finding from 1 review
- no estimate extracted1 study · 20 participantsVery low
Bromperidol decanoate vs placebo
Quality of life · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Bromperidol decanoate vs placebo
Weight gain · patients with schizophrenia
Bromperidol decanoate showed no clear difference in adverse effects ‐ increased weight compared with placebo (low certainty).
1 finding from 1 review
- RR 3 [0.14, 65.9]1 study · 20 participantsLow
Bromperidol decanoate vs placebo
Adverse effects ‐ stiffness · patients with schizophrenia
Bromperidol decanoate showed no clear difference in adverse effects ‐ stiffness compared with placebo (low certainty).
1 finding from 1 review
- RR 0.25 [0.03, 1.86]1 study · 20 participantsLow
Bromperidol decanoate vs other depot antipsychotic drugs
Relapse · patients with schizophrenia
Bromperidol decanoate may leads to higher global state: Relapse compared with other depot antipsychotic drugs (low certainty).
1 finding from 1 review
- RR 3.92 [1.05, 14.6]2 studies · 67 participantsLow
Bromperidol decanoate vs other depot antipsychotic drugs
Hospital admissions · patients with schizophrenia
Bromperidol decanoate showed no clear difference in global state: Hospital admission compared with other depot antipsychotic drugs (low certainty).
1 finding from 1 review
- RR 1.72 [0.7, 4.24]2 studies · 67 participantsLow
Bromperidol decanoate vs other depot antipsychotic drugs
Global state: Response ‐ proxy outcome ‐ mental state: 1. General ‐ average score (Brief Psychiatric Rating Scale by over 24 weeks · patients with schizophrenia
1 finding from 1 review
- no estimate extracted1 study · 30 participantsVery low